Leading physicians in India appear to be generally backing wider but appropriate use of inhaled budesonide following promising data from the UK on use of the glucocorticoid in improving COVID-19 treatment outcomes.
The UK’s Platform Randomised Trial of Interventions against COVID-19 in Older People (PRINCIPLE) trial recently indicated that the commonly used asthma therapy could shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?